226 related articles for article (PubMed ID: 26179261)
1. Up-regulated Circulating miR-106a by DNA Methylation Promised a Potential Diagnostic and Prognostic Marker for Gastric Cancer.
Yuan R; Wang G; Xu Z; Zhao H; Chen H; Han Y; Wang B; Zhou J; Hu H; Guo Z; Shen H; Xue X
Anticancer Agents Med Chem; 2016; 16(9):1093-100. PubMed ID: 26179261
[TBL] [Abstract][Full Text] [Related]
2. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
4. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.
Zhang J; Dai WJ; Yang XZ
Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic significance of miR-106a in gastric cancer.
Hou X; Zhang M; Qiao H
Int J Clin Exp Pathol; 2015; 8(10):13096-101. PubMed ID: 26722506
[TBL] [Abstract][Full Text] [Related]
6. Detection of miR-106a in gastric carcinoma and its clinical significance.
Xiao B; Guo J; Miao Y; Jiang Z; Huan R; Zhang Y; Li D; Zhong J
Clin Chim Acta; 2009 Feb; 400(1-2):97-102. PubMed ID: 18996365
[TBL] [Abstract][Full Text] [Related]
7. Similarly up-regulated microRNA-106a in matched formalin-fixed paraffin-embedded and fresh frozen samples and the dynamic changes during gastric carcinogenesis and development.
Zhu M; Zhang N; He S
Pathol Res Pract; 2014 Dec; 210(12):909-15. PubMed ID: 25115709
[TBL] [Abstract][Full Text] [Related]
8. Upregulated expression of miR-106a by DNA hypomethylation plays an oncogenic role in hepatocellular carcinoma.
Yuan R; Zhi Q; Zhao H; Han Y; Gao L; Wang B; Kou Z; Guo Z; He S; Xue X; Hu H
Tumour Biol; 2015 Apr; 36(4):3093-100. PubMed ID: 25510666
[TBL] [Abstract][Full Text] [Related]
9. Up-Regulation of Plasma miR-23b is Associated with Poor Prognosis of Gastric Cancer.
Zhuang K; Han K; Tang H; Yin X; Zhang J; Zhang X; Zhang L
Med Sci Monit; 2016 Feb; 22():356-61. PubMed ID: 26835790
[TBL] [Abstract][Full Text] [Related]
10. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
11. Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia.
Chen X; Lin Z; Xue M; Si J; Chen S
PLoS One; 2015; 10(7):e0133906. PubMed ID: 26207911
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis.
Steponaitiene R; Kupcinskas J; Langner C; Balaguer F; Venclauskas L; Pauzas H; Tamelis A; Skieceviciene J; Kupcinskas L; Malfertheiner P; Link A
Mol Carcinog; 2016 Apr; 55(4):376-86. PubMed ID: 25663388
[TBL] [Abstract][Full Text] [Related]
13. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated expression of sulfatases (SULF1 and SULF2) as prognostic and metastasis predictive markers in human gastric cancer.
Hur K; Han TS; Jung EJ; Yu J; Lee HJ; Kim WH; Goel A; Yang HK
J Pathol; 2012 Sep; 228(1):88-98. PubMed ID: 22653794
[TBL] [Abstract][Full Text] [Related]
15. A Clinical Evaluation of Circulating MiR-106a and Raf-1 as Breast Cancer Diagnostic and Prognostic Markers.
Ahmed Mohmmed E; Shousha WG; El-Saiid AS; Ramadan SS
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3513-3520. PubMed ID: 34837907
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer.
Juzėnas S; Saltenienė V; Kupcinskas J; Link A; Kiudelis G; Jonaitis L; Jarmalaite S; Kupcinskas L; Malfertheiner P; Skieceviciene J
PLoS One; 2015; 10(7):e0132327. PubMed ID: 26172537
[TBL] [Abstract][Full Text] [Related]
17. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
[TBL] [Abstract][Full Text] [Related]
18. Potential diagnostic and prognostic value of plasma long noncoding RNA LINC00086 and miR-214 expression in gastric cancer.
Ji B; Huang Y; Gu T; Zhang L; Li G; Zhang C
Cancer Biomark; 2019; 24(2):249-255. PubMed ID: 30689553
[TBL] [Abstract][Full Text] [Related]
19. [Expression of plasma miR-106a in colorectal cancer and its clinical significance].
Zhang L; Meng L; Fan Z; Liu B; Pei Y; Zhao Z
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):354-7. PubMed ID: 24670448
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer.
Ahadi A
Immunogenetics; 2021 Apr; 73(2):155-161. PubMed ID: 33399935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]